Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 25.31
(10.0%)
CNY 25.31
(10.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 109.1 Million CNY | 713.43% |
| 2022 | 13.41 Million CNY | -45.44% |
| 2021 | 24.58 Million CNY | -86.43% |
| 2020 | 181.14 Million CNY | 653.5% |
| 2019 | 24.04 Million CNY | -31.31% |
| 2018 | 35 Million CNY | -46.15% |
| 2017 | 65 Million CNY | 30.0% |
| 2016 | 50 Million CNY | 0.0% |
| 2014 | 72 Million CNY | -23.4% |
| 2013 | 94 Million CNY | 51.61% |
| 2012 | 62 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 37.31 Million CNY | -65.8% |
| 2024 Q2 | 112.14 Million CNY | 200.55% |
| 2024 Q3 | 66.83 Million CNY | -44.92% |
| 2023 Q3 | 8.51 Million CNY | -9.76% |
| 2023 Q4 | 109.1 Million CNY | 1180.59% |
| 2023 FY | 109.1 Million CNY | 713.43% |
| 2023 Q1 | 53.62 Million CNY | 299.82% |
| 2023 Q2 | 9.44 Million CNY | -82.4% |
| 2022 Q4 | 13.41 Million CNY | -27.58% |
| 2022 FY | 13.41 Million CNY | -45.44% |
| 2022 Q3 | 18.52 Million CNY | -6.01% |
| 2022 Q2 | 19.7 Million CNY | -11.89% |
| 2022 Q1 | 22.36 Million CNY | -9.03% |
| 2021 Q2 | 30.01 Million CNY | 78.37% |
| 2021 Q3 | 29.64 Million CNY | -1.22% |
| 2021 Q1 | 16.82 Million CNY | 0.0% |
| 2021 FY | 24.58 Million CNY | -86.43% |
| 2021 Q4 | 24.58 Million CNY | -17.07% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 FY | 181.14 Million CNY | 653.5% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q2 | 24 Million CNY | 0.0% |
| 2019 FY | 24.04 Million CNY | -31.31% |
| 2019 Q4 | 24.04 Million CNY | 0.0% |
| 2019 Q3 | 24.04 Million CNY | 0.17% |
| 2019 Q1 | 24 Million CNY | 0.0% |
| 2018 FY | 35 Million CNY | -46.15% |
| 2017 FY | 65 Million CNY | 30.0% |
| 2016 FY | 50 Million CNY | 0.0% |
| 2014 FY | 72 Million CNY | -23.4% |
| 2013 FY | 94 Million CNY | 51.61% |
| 2012 FY | 62 Million CNY | 0.0% |